Journal «Metabolism and somatic diseases»

Journal «Metabolism and somatic diseases»

"Metabolism and somatic diseases" is a medical journal for specialists in different fields of medicine – from internal medicine to interventional cardiology, from basic science to engineering of medical equipment . The journal is published four times a year in two languages (English and Russian) in printed and electronic forms. Printed version is available for free. All issues of journal are available for free on official website www.cardioprogress.ru.

The journal is registered by the Ministry for Press, Broadcasting and Mass Communications of Russian Federation 30.07.2013 (PI № FS 77-54593).

The format of publications

The journal publishes editorials, papers on original research, review articles, experts’ opinion, guidelines, letter to editor-in-chief.

Main topics

Publication of scientific materials and articles for authors free of charge.

Circulation is 3000 copies. Published in Russia.

Scientific news

  • Weight Loss During Heart Failure Hospitalization Linked to Lower 30-Day Rehospitalization Risk Patients hospitalized for heart failure who were treated with intravenous loop diuretics and achieved a weight loss of at least 2 kg between admission and discharge had a reduced risk for HF rehospitalization within 30 days.
  • Allergic vasospastic angina: a systematic review Allergic vasospastic angina (also known as Kunis syndrome) is a little‑studied subtype of vasospastic angina in which spasm of the coronary arteries is triggered by an allergen. Scientists conducted a study in which they assessed the clinical characteristics, mechanisms, and treatment methods for this interesting subtype of angina.
  • Fitness Changes Over Time Linked to Cardiovascular Risk A large UK Biobank analysis showed that even a small annual improvement in cardiorespiratory fitness among adults was independently associated with lower risks for incident cardiovascular disease and cardiovascular mortality, whereas declining fitness was linked to a progressively higher risk in a clear dose-dependent pattern.
  • Cardioprotection Rarely Used in Adults With Blood Cancers In a US cohort study of adults on anthracycline-based therapy for hematologic cancers, only 1%-2% received strategies to lower the risk for treatment-related heart damage.
  • New horizons of cardiotherapy Since the introduction of the first implantable stimulator and defibrillator (ICD), cardiological science has advanced far. ICDs are highly effective, but their main disadvantage is the complications associated with the electrodes. To avoid the need for venous access and complications caused by transvenous electrodes, a fully subcutaneous ICD system (pc-ICD) was developed.

Partners

Video resource

Channel "Cardioprogress"

Follow us

Top.Mail.Ru